885321-46-0

Basic information

• Product Name: (R)-4-tert-butyl 3-Methyl Morpholine-3,4-dicarboxylate
• Synonyms: (R)-4-tert-butyl 3-Methyl Morpholine-3,4-dicarboxylate;(3R)-3,4-Morpholinedicarboxylic acid, 4-(1,1-diMethylethyl) 3-Methyl ester;(R)-4-(tert-butoxycarbonyl)-3-MethylMorpholine-3-carboxylic acid;(R)-4-tert-butyl 3-Methyl thioMorpholine-3,4-dicarboxylate;(R)-tert-butyl methyl morpholine-3,4-dicarboxylate
• CAS NO: 885321-46-0
• Molecular Formula: C11H19NO5
• Molecular Weight: 245.27226
• Mol File: 885321-46-0.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (R)-4-tert-butyl 3-Methyl Morpholine-3,4-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-tert-butyl 3-Methyl Morpholine-3,4-dicarboxylate(885321-46-0)
• EPA Substance Registry System: (R)-4-tert-butyl 3-Methyl Morpholine-3,4-dicarboxylate(885321-46-0)

Safety Data

• Hazardous Substances Data: 885321-46-0(Hazardous Substances Data)

Usage

General Description

(R)-4-tert-butyl 3-Methyl Morpholine-3,4-dicarboxylate is a chemical compound that is commonly used as an intermediate for the synthesis of pharmaceuticals. It is a morpholine derivative with two carboxyl groups and a tert-butyl group, making it a versatile building block for the production of various drugs. (R)-4-tert-butyl 3-Methyl Morpholine-3,4-dicarboxylate has potential applications in the development of drugs for a range of therapeutic uses. Its unique structure and functional groups make it valuable for the pharmaceutical industry, and it is often utilized in drug discovery and development processes. Additionally, its stereochemistry and specific functional groups make it a valuable tool for medicinal chemistry research.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1235387-14-0 C₁₃H₁₇NO₃ 
• 67-56-1 methanol 
• 783350-37-8 (S)-4-[(tert-butoxy)carbonyl]morpholine-3-carboxylic acid 
• 106825-79-0 (S)-morpholine-3-carboxylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 74-88-4 methyl iodide 
• 126264-49-1 methyl 3-morpholine-carboxylate 
• 212650-43-6 4-(tert-butoxycarbonyl)morpholine-3-carboxylic acid 
• 1235387-14-0 C₁₃H₁₇NO₃ 
• 885321-34-6 (R)-3-(tert-butyldiphenylsilyloxymethyl)morpholine 
• 714971-28-5 (S)-3-(hydroxymethyl)morpholine-4-carboxylic acid tert-butyl ester 
• 211053-50-8 (S)-3-(hydroxymethyl)morpholine 
• 869681-70-9 (R)-morpholine-3,4-dicarboxylic acid 4-tert-butyl ester 

Downstream Products

• 212650-43-6 4-(tert-butoxycarbonyl)morpholine-3-carboxylic acid 
• 1101987-05-6 N,N-dimethylmorpholine-3-carboxamide 
• 783350-37-8 (S)-4-[(tert-butoxy)carbonyl]morpholine-3-carboxylic acid 
• 869681-70-9 (R)-morpholine-3,4-dicarboxylic acid 4-tert-butyl ester 
• 1447972-26-0 methyl (3S)-morpholine-3-carboxylate hydrochloride 

Relevant articles and documents

Tricyclic dihydroimidazopyrimidinone derivative, and preparation method, pharmaceutical composition and application thereof

The invention provides a compound as shown in a general formula (I), cis-trans isomers, enantiomers, diastereoisomers, racemes, solvates, hydrates or pharmaceutically acceptable salts or prodrugs of the compound, a preparation method of the compound, a pharmaceutical composition containing the compound and an application of the compound as aLp-PLA2 inhibitor, wherein R1, R2, Rx, Ra, Q, U, X, Y, m, n and A are defined in the specification.

Synthesis of 3-oxadiazolyl/triazolyl morpholines: Novel scaffolds for drug discovery

Synthesis of isomeric 3-oxadiazolyl/triazolyl morpholines was performed based on a common intermediate on the gram scale. The target compounds were designed as novel scaffolds for the medicinal chemistry. The key reaction was an electrochemical CH-oxidati

COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.